Department of Health
and Human Services (HHS)
and Human Services (HHS)
October 14, 2020
RFA-MH-18-702 - Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required)
NOT-MH-21-020 - Notice of Extension to RFA-MH-18-700, "Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required)
NOT-MH-21-021 - Notice of Extension to RFA-MH-18-701, "Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
NOT-MH-21-023 - Notice of Extension to RFA-MH-18-703, "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
NOT-MH-21-024 - Notice of Extension to RFA-MH-18-704, "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33- Clinical Trial Required)
NOT-MH-21-025 - Notice of Extension to RFA-MH-18-705, "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
NOT-MH-21-026 - Notice of Extension to RFA-MH-18-706, "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)
NOT-MH-21-027 - Notice of Extension to RFA-MH-18-707, "Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
National Institute of Mental Health (NIMH)
This Notice extends the expiration date for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required)" for one additional receipt date.
Changes to Key Dates apply to Part 1. Overview Information, Key Dates. Due to the extension, the following application due date will be added: February 18, 2021.
Current Expiration Date: October 16, 2020.
New Expiration Date: February 19, 2021.
Changes are reflected in italics as follows:
Changes to Key Dates
Currently Reads:
Part 1. Overview Information
Key Dates
| Posted Date | November 14, 2017 |
| Open Date (Earliest Submission Date) | January 14, 2018 |
| Letter of Intent Due Date(s) | 30 days prior to the application due date |
| Application Due Date(s) |
New Dates February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) |
Not Applicable |
| Scientific Merit Review | New Dates June 2018, October 2018, March 2019,June 2019, October 2019, March 2020, June 2020, October 2020, March 2021 |
| Advisory Council Review | New Dates October 2018, January 2019, May 2019,October 2019, January 2020, May 2020, October 2020, January 2021, May 2021 |
| Earliest Start Date | New Dates December 2018, February 2019, June 2019, December 2019, February 2020, June 2020, December 2020, February 2021, June 2021 |
| Expiration Date | New Date October 16, 2020 per issuance of NOT-MH-18-050. (Original Expiration Date: October 16, 2018) |
| Due Dates for E.O. 12372 | Not Applicable |
Modified to read:
Part 1. Overview Information
Key Dates
| Posted Date | November 14, 2017 |
| Open Date (Earliest Submission Date) | January 14, 2018 |
| Letter of Intent Due Date(s) | 30 days prior to the application due date |
| Application Due Date(s) |
New Dates February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020; February 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) |
Not Applicable |
| Scientific Merit Review | New Dates June 2018, October 2018, March 2019,June 2019, October 2019, March 2020, June 2020, October 2020, March 2021, June 2021 |
| Advisory Council Review | New Dates October 2018, January 2019, May 2019,October 2019, January 2020, May 2020, October 2020, January 2021, May 2021, October 2021 |
| Earliest Start Date | New Dates December 2018, February 2019, June 2019, December 2019, February 2020, June 2020, December 2020, February 2021, June 2021, December 2021 |
| Expiration Date | New Date February 19, 2021 |
| Due Dates for E.O. 12372 | Not Applicable |
All other aspects of this FOA remain unchanged.
Refer to the FOA for specific research contacts.